AcBel Polytech Inc. (TPE:6282)

CTI BioPharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24,042	25,980	35,435	15,710	18,908	14,956
Market Cap Growth	-25.71%	-26.68%	125.56%	-16.92%	26.42%	19.88%
Enterprise Value	29,156	31,239	41,191	21,535	22,321	13,587
Last Close Price	28.00	30.25	40.51	27.92	33.17	25.10
PE Ratio	3582.99	-	773.82	24.69	31.41	11.39
Forward PE	-	19.23	19.23	19.23	19.23	15.57
PS Ratio	0.76	0.82	1.27	0.63	0.86	0.71
PB Ratio	1.04	1.11	1.51	1.46	1.80	1.41
P/TBV Ratio	1.81	1.92	2.68	1.56	1.91	1.50
P/FCF Ratio	38.05	-	23.04	207.66	-	-
P/OCF Ratio	13.94	12.01	9.14	8.94	-	12.47
EV/Sales Ratio	0.92	0.99	1.48	0.87	1.02	0.65
EV/EBITDA Ratio	17.98	25.99	26.31	17.77	20.81	15.13
EV/EBIT Ratio	-	-	76.49	46.65	53.48	34.73
EV/FCF Ratio	46.14	-	26.79	284.66	-	-
Debt / Equity Ratio	0.55	0.55	0.56	1.23	0.94	0.72
Debt / EBITDA Ratio	7.87	8.36	7.04	9.40	8.14	7.60
Debt / FCF Ratio	19.87	-	8.53	174.36	-	-
Asset Turnover	0.66	0.63	0.68	0.77	0.76	0.85
Inventory Turnover	3.44	3.34	3.29	3.63	4.33	4.89
Quick Ratio	1.07	0.89	1.11	1.38	0.92	1.15
Current Ratio	1.62	1.48	1.67	1.94	1.34	1.41
Return on Equity (ROE)	-0.04%	-0.15%	0.22%	5.25%	6.33%	13.63%
Return on Assets (ROA)	-0.13%	-0.15%	0.82%	0.89%	0.91%	0.99%
Return on Capital (ROIC)	-0.17%	-0.21%	1.11%	1.30%	1.35%	1.58%
Return on Capital Employed (ROCE)	-	-	1.60%	2.00%	2.50%	2.80%
Earnings Yield	0.03%	-0.12%	0.13%	4.05%	3.18%	8.78%
FCF Yield	2.63%	-2.51%	4.34%	0.48%	-25.10%	-11.67%
Dividend Yield	1.81%	-	1.23%	0.72%	3.02%	4.78%
Payout Ratio	6422.21%	-	229.78%	81.18%	102.98%	43.28%
Buyback Yield / Dilution	-14.68%	-13.35%	-19.35%	-22.16%	0.23%	-0.11%
Total Shareholder Return	-12.87%	-13.35%	-18.12%	-21.44%	3.25%	4.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.